Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2004

Feb 20, 2004

34519_dirs_2004-02-20_7de587c5-1338-435b-aee3-fde09a7122be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2004-02-18

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-02-18 Common Stock, par value $0.10 per share P 600 $4.34 Acquired 366460 Direct
2004-02-18 Common Stock, par value $0.10 per share P 900 $4.35 Acquired 367360 Direct
2004-02-18 Common Stock, par value $0.10 per share P 700 $4.35 Acquired 368060 Direct
2004-02-19 Common Stock, par value $0.10 per share P 500 $4.36 Acquired 368560 Direct
2004-02-19 Common Stock, par value $0.10 per share P 800 $4.45 Acquired 369360 Direct
2004-02-19 Common Stock, par value $0.10 per share P 1000 $4.45 Acquired 370360 Direct
2004-02-20 Common Stock, par value $0.10 per share P 600 $4.42 Acquired 370960 Direct
2004-02-20 Common Stock, par value $0.10 per share P 1400 $4.42 Acquired 372360 Direct
2004-02-20 Common Stock, par value $0.10 per share P 100 $4.41 Acquired 372460 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.